Equioxx

RSS

firocoxib

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Equioxx.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Equioxx.

For practical information about using Equioxx, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 27/10/2020

Authorisation details

Product details
Name
Equioxx
Agency product number
EMEA/V/C/000142
Active substance
firocoxib
International non-proprietary name (INN) or common name
firocoxib
Species
Horses
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AH90
Publication details
Marketing-authorisation holder
Audevard
Revision
8
Date of issue of marketing authorisation valid throughout the European Union
25/06/2008
Contact address

42-46 rue Mederic
92582 Clichy Cedex
France

Product information

14/10/2020 Equioxx - EMEA/V/C/000142 - T/0022

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Anti-inflammatory and anti-rheumatic products, non-steroids

Therapeutic indication

Alleviation of pain and inflammation associated with osteoarthritis and reduction of associated lameness in horses.

Assessment history

How useful was this page?

Add your rating
Average
1 rating